Skin Ulcer News - LARVOL Sigma

Skin Ulcer

Welcome, Profile Billing Logout

22 Mechanisms of Action

«1 2 3 4 5 6 7 8 9 10 111213 »

||||||||||  LeukoScan (sulesomab) / Gilead
Enrollment open:  ISEOD: PET/CT Scanning for the Follow-up of Antibiotic Treatment of Infectious Osteoarthritis in the Diabetic Foot (clinicaltrials.gov) -  Jul 25, 2012
P=N/A, N=109, Recruiting,  Sponsor: Centre Hospitalier Universitaire de Nīmes
Not yet recruiting --> Recruiting

|||||||||| Enrollment change: The Foot in Your Nose Study: Links Between Nasal Staphylococcus Aureus Colonies and Diabetic Foot Lesion Infections (clinicaltrials.gov) - Jul 24, 2012
P=N/A, N=278, Completed, Sponsor: Centre Hospitalier Universitaire de Nīmes
Not yet recruiting --> Recruiting N=401 --> 278

|||||||||| Trial completion: The Foot in Your Nose Study: Links Between Nasal Staphylococcus Aureus Colonies and Diabetic Foot Lesion Infections (clinicaltrials.gov) - Jul 24, 2012
P=N/A, N=278, Completed, Sponsor: Centre Hospitalier Universitaire de Nīmes
N=401 --> 278 Recruiting --> Completed

|||||||||| Trial termination: A Comparison of an Investigational Dressing to Tegaderm Matrix Wound Dressing in the Management of Diabetic Foot Ulcers (clinicaltrials.gov) - Jul 22, 2012
P=N/A, N=43, Terminated, Sponsor: 3M
Recruiting --> Completed Recruiting --> Terminated; Expired study materials; low subject recruitment

|||||||||| Enrollment change: A Comparison of an Investigational Dressing to Tegaderm Matrix Wound Dressing in the Management of Diabetic Foot Ulcers (clinicaltrials.gov) - Jul 22, 2012
P=N/A, N=43, Terminated, Sponsor: 3M
Recruiting --> Terminated; Expired study materials; low subject recruitment N=150 --> 43

|||||||||| Trial initiation date: A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE) (clinicaltrials.gov) - Jul 18, 2012
P2, N=168, Completed, Sponsor: CoDa Therapeutics Inc.
N=150 --> 43 Initiation date: Feb 2012 --> Jul 2012

|||||||||| Clinical: A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers (clinicaltrials.gov) - Jul 18, 2012
P=N/A, N=110, Recruiting, Sponsor: Electrochemical Oxygen Concepts, Inc.

|||||||||| Trial termination: Silica Gel Fiber Wound Dressing for Chronic Venous Leg Ulcers (clinicaltrials.gov) - Jul 15, 2012
P2, N=126, Terminated, Sponsor: Bayer
Initiation date: Feb 2012 --> Jul 2012 Completed --> Terminated

|||||||||| Enrollment closed: Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus (clinicaltrials.gov) - Jul 11, 2012
P3, N=176, Active, not recruiting, Sponsor: Daewoong Pharmaceutical Co. LTD.
Completed --> Terminated Recruiting --> Active, not recruiting

|||||||||| New P3 trial: August2: Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia (clinicaltrials.gov) - Jul 9, 2012
P3, N=34, Terminated, Sponsor: GWT-TUD GmbH

||||||||||  morphine sulphate / Generic mfg.
Trial withdrawal:  Analgesia and Wound Healing Assessment Following Topical Morphine Applied to Patients With Cutaneous Cancer Related Pain (clinicaltrials.gov) -  Jul 2, 2012
P=N/A, N=0, Withdrawn,  Sponsor: Soroka University Medical Center
Recruiting --> Active, not recruiting Recruiting --> Withdrawn

||||||||||  morphine sulphate / Generic mfg.
Enrollment change:  Analgesia and Wound Healing Assessment Following Topical Morphine Applied to Patients With Cutaneous Cancer Related Pain (clinicaltrials.gov) -  Jul 2, 2012
P=N/A, N=0, Withdrawn,  Sponsor: Soroka University Medical Center
Recruiting --> Withdrawn N=60 --> 0

|||||||||| Trial completion: A Multi-centre Evaluation of the Performance of Window Dressings on Subjects With High Risk Pressure Ulceration (clinicaltrials.gov) - Jul 1, 2012
P4, N=29, Completed, Sponsor: Molnlycke Health Care AB
N=60 --> 0 Recruiting --> Completed

|||||||||| New P3 trial: Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus (clinicaltrials.gov) - Jun 25, 2012
P3, N=176, Active, not recruiting, Sponsor: Daewoong Pharmaceutical Co. LTD.

|||||||||| Enrollment change: Feasibility Study to Evaluate the Safety of Topically Applied Revera in Subjects With Venous Leg Ulcers (clinicaltrials.gov) - Jun 21, 2012
P1, N=13, Completed, Sponsor: Revalesio Corporation
Recruiting --> Completed N=24 --> 13

|||||||||| Trial completion: Feasibility Study to Evaluate the Safety of Topically Applied Revera in Subjects With Venous Leg Ulcers (clinicaltrials.gov) - Jun 21, 2012
P1, N=13, Completed, Sponsor: Revalesio Corporation
N=24 --> 13 Active, not recruiting --> Completed

|||||||||| Enrollment change: WOUND: Interdisciplinary Pressure Management & Mobility Program as an Alternative to Usual Care: A Pilot Study (clinicaltrials.gov) - Jun 3, 2012
P3, N=14, Completed, Sponsor: University of Western Ontario, Canada
Active, not recruiting --> Completed N=20 --> 14

|||||||||| Trial completion: WOUND: Interdisciplinary Pressure Management & Mobility Program as an Alternative to Usual Care: A Pilot Study (clinicaltrials.gov) - Jun 3, 2012
P3, N=14, Completed, Sponsor: University of Western Ontario, Canada
N=20 --> 14 Recruiting --> Completed

|||||||||| New P4 trial: RESPOND Restoring Equilibrium and Wound Stimulation to Promote Healing Of Non-healing DFUs (clinicaltrials.gov) - May 29, 2012
P4, N=13, Terminated, Sponsor: Celleration, Inc.

|||||||||| Enrollment open: Effects of Non Contact Low Frequency Ultrasound in Healing Venous Leg Ulcers (clinicaltrials.gov) - May 28, 2012
P=N/A, N=208, Recruiting, Sponsor: Celleration, Inc.
Recruiting --> Completed Not yet recruiting --> Recruiting

|||||||||| Enrollment open: Efficacy Study of IZN-6D4 Gel for the Treatment of Diabetic Foot Ulcers (clinicaltrials.gov) - May 22, 2012
P2, N=80, Recruiting, Sponsor: Izun Pharma Ltd
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting

||||||||||  Grafix (cryopreserved placental membrane) / Osiris
New P4 trial:  Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers (clinicaltrials.gov) -  May 9, 2012
P4, N=97, Completed,  Sponsor: Osiris Therapeutics

||||||||||  Locilex (pexiganan acetate) / PLx Pharma Inc
New P3 trial, Head-to-Head:  OneStep-2: Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (clinicaltrials.gov) -  May 7, 2012
P3, N=180, Not yet recruiting,  Sponsor: Dipexium Pharmaceuticals, LLC

|||||||||| New P3 trial: Study to Evaluate the Performance of AQUACEL® Extra™ in Venous Leg Ulcers (clinicaltrials.gov) - May 2, 2012
P3, N=65, Completed, Sponsor: ConvaTec Inc.

||||||||||  Locilex (pexiganan acetate) / PLx Pharma Inc
New P3 trial, Head-to-Head:  OneStep-1: Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (clinicaltrials.gov) -  May 1, 2012
P3, N=180, Not yet recruiting,  Sponsor: Dipexium Pharmaceuticals, LLC

|||||||||| Enrollment open: SAS-FOOT: Impact of Sleep Apnea on Diabetic Foot Wound. (clinicaltrials.gov) - May 1, 2012
P=N/A, N=60, Recruiting, Sponsor: AGIR à Dom
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting

|||||||||| New P3 trial: SANIBA: Off- Loading Shoe to Improve Healing and Prevention of Recurrence of Neuropathic Diabetic Plantar Foot Ulcers (clinicaltrials.gov) - Apr 24, 2012
P3, N=33, Completed, Sponsor: Assistance Publique - H

|||||||||| Trial completion: EASH Dressing on Chronic Venous Leg Ulcers (clinicaltrials.gov) - Apr 23, 2012
P2, N=40, Completed, Sponsor: ConvaTec Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed

|||||||||| Clinical: Dynamic Plantar Microvascular Skin Response to Compressive Loads in At-risk Diabetic and Healthy Control: a Pilot Study (clinicaltrials.gov) - Apr 16, 2012
P=N/A, N=50, Recruiting, Sponsor: Temple University

|||||||||| New P4 trial: Wound Fluid Protease Levels During Use of Novel Wound Dressing (clinicaltrials.gov) - Mar 28, 2012
P4, N=30, Recruiting, Sponsor: Hollister Incorporated

|||||||||| New P1/2 trial: Autologous Bone Marrow Stem Cells in Pressure Ulcer Treatment (clinicaltrials.gov) - Mar 27, 2012
P1/2, N=30, Recruiting, Sponsor: Hospital Universitario Central de Asturias

|||||||||| Trial completion: Treatment of Cutaneous Ulcers With a Novel Biological Dressing (clinicaltrials.gov) - Mar 26, 2012
P1/2, N=6, Completed, Sponsor: Centre Hospitalier Universitaire de Québec, CHU de Québec
Active, not recruiting --> Completed Recruiting --> Completed

||||||||||  Cubicin (daptomycin) / Merck (MSD)
Trial termination:  Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment (clinicaltrials.gov) -  Mar 25, 2012
P3, N=1, Terminated,  Sponsor: Ruhr University of Bochum
Recruiting --> Completed Recruiting --> Terminated; Patient number to be enrolled not reachable in prospected time frame, decision to stop the study prematurely was made.

||||||||||  Cubicin (daptomycin) / Merck (MSD)
Enrollment change:  Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment (clinicaltrials.gov) -  Mar 25, 2012
P3, N=1, Terminated,  Sponsor: Ruhr University of Bochum
Recruiting --> Terminated; Patient number to be enrolled not reachable in prospected time frame, decision to stop the study prematurely was made. N=120 --> 1

|||||||||| Trial completion: Evaluation of Negative Pressure Wound Therapy in the Treatment of DFUs Incl. Post Amputation Wounds. (clinicaltrials.gov) - Mar 19, 2012
P=N/A, N=16, Completed, Sponsor: Molnlycke Health Care AB
N=120 --> 1 Recruiting --> Completed

|||||||||| Enrollment open: Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers (clinicaltrials.gov) - Mar 18, 2012
P=N/A, N=100, Recruiting, Sponsor: MiMedx Group, Inc.
Recruiting --> Completed Not yet recruiting --> Recruiting

|||||||||| Trial completion: A Dose Finding Study of Topically Applied I-020201 as an Adjunct to Good Standard-of-care in Patients With Chronic Diabetic Foot Ulcers (clinicaltrials.gov) - Mar 14, 2012
P2, N=211, Completed, Sponsor: Kuros Biosurgery AG
Not yet recruiting --> Recruiting Active, not recruiting --> Completed

|||||||||| New P3 trial: An Open, Uncontrolled Study of GK567 in the Deodorization of Malodorous Fungating Neoplastic Tumours (clinicaltrials.gov) - Feb 28, 2012
P3, N=21, Completed, Sponsor: Galderma R&D

|||||||||| Trial initiation date: Split Thickness Donor Site Healing With MIST Study (clinicaltrials.gov) - Feb 22, 2012
P=N/A, N=30, Enrolling by invitation, Sponsor: Celleration, Inc.
Active, not recruiting --> Completed Initiation date: Oct 2010 --> Feb 2012

|||||||||| Enrollment open: Split Thickness Donor Site Healing With MIST Study (clinicaltrials.gov) - Feb 22, 2012
P=N/A, N=30, Enrolling by invitation, Sponsor: Celleration, Inc.
Initiation date: Oct 2010 --> Feb 2012 Not yet recruiting --> Enrolling by invitation

|||||||||| Trial completion: Efficacy Study of a Bioelectric Dressing Used With Negative Pressure Wound Therapy to Treat Diabetic and Pressure Ulcers (clinicaltrials.gov) - Feb 19, 2012
P2, N=30, Completed, Sponsor: Vomaris Innovations
Not yet recruiting --> Enrolling by invitation Recruiting --> Completed

|||||||||| Trial completion: Self-Management to Prevent Ulcers in Veterans With SCI (Spinal Cord Injury) (clinicaltrials.gov) - Feb 14, 2012
P=N/A, N=400, Completed, Sponsor: Department of Veterans Affairs
Recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion: Compare Aquacel® Ag Versus Mepilex® Border Ag to Manage Bioburden in Leg Ulcers (clinicaltrials.gov) - Feb 7, 2012
P3, N=18, Completed, Sponsor: ConvaTec Inc.
Active, not recruiting --> Completed Recruiting --> Completed

|||||||||| New P3 trial: PED111: Study of the Efficacy of PedyPhar® Ointment on the Diabetic Foot Ulcers (clinicaltrials.gov) - Feb 5, 2012
P3, N=120, Recruiting, Sponsor: European Egyptian Pharmaceutical Industries

|||||||||| Enrollment open: HADIF: HELP-Apheresis in Diabetic Ischemic Foot Treatment (H.A.D.I.F) (clinicaltrials.gov) - Feb 2, 2012
P=N/A, N=132, Recruiting, Sponsor: Universita di Verona
Recruiting --> Completed Not yet recruiting --> Recruiting

|||||||||| Trial completion: A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot) (clinicaltrials.gov) - Jan 24, 2012
P2, N=7, Completed, Sponsor: Skingenix, Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed

|||||||||| Trial completion: A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers (clinicaltrials.gov) - Jan 24, 2012
P2, N=5, Completed, Sponsor: Skingenix, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Enrollment change: Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers (clinicaltrials.gov) - Jan 23, 2012
P2, N=6, Terminated, Sponsor: Nitric BioTherapeutics, Inc
Active, not recruiting --> Completed N=60 --> 6

|||||||||| Trial termination: Reduction of Bacteria in MRSA Positive Ulcers (clinicaltrials.gov) - Jan 17, 2012
P1/2, N=20, Terminated, Sponsor: Nitric BioTherapeutics, Inc
N=60 --> 6 Active, not recruiting --> Terminated; limited recruitment

|||||||||| Enrollment change: Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers (clinicaltrials.gov) - Jan 17, 2012
P2, N=4, Terminated, Sponsor: Nitric BioTherapeutics, Inc
Active, not recruiting --> Terminated; limited recruitment N=30 --> 4